Worth Venture Partners’s Pulmonx LUNG Stock Holding History

Worth Venture Partners’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-32,525	Closed	-$71.9K	–	62
2025 Q4	$71.9K	Buy	+32,525	New	+$61.1K	0.52%	51

Other funds holding LUNG

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Worth Venture Partners's LUNG Position: Q1 2026 in Review

Worth Venture Partners sold out of Pulmonx (LUNG) in Q1 2026, closing a stake of 32,525 shares — an estimated $71.9K sold.

Worth Venture Partners first reported a position in LUNG in Q4 2025 and held it in 1 quarter. The position peaked at $71.9K in Q4 2025. 114 funds tracked by Wall St. Rank hold LUNG as of Q1 2026.

Worth Venture Partners reported no remaining Pulmonx position as of Q1 2026 after selling out during the quarter.
Worth Venture Partners sold 32,525 Pulmonx shares in Q1 2026, an estimated $71.9K.
Worth Venture Partners first reported a position in Pulmonx in Q4 2025 and held it in 1 quarter.
Worth Venture Partners's Pulmonx position peaked at $71.9K in Q4 2025.
114 funds tracked by Wall St. Rank held Pulmonx as of Q1 2026.

Based on Worth Venture Partners's 13F filing for Q1 2026, filed 14 May 2026.